Off‐label use of nicardipine as tocolytic and acute pulmonary oedema: a post‐marketing analysis of adverse drug reaction reports in EudraVigilance

Publisher： John Wiley & Sons Inc

E-ISSN： 1099-1557|24|11|1220-1224

ISSN： 1053-8569

Source： PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, Vol.24, Iss.11, 2015-11, pp. : 1220-1224

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

An algorithm to detect unexpected increases in frequency of reports of adverse events in EudraVigilance

By  

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, Vol. 27, Iss. 1, 2018-01 ,pp. : 38-45

John Wiley & Sons Inc

Access to resources Recommend Favorite

Off-label drug use ‐ price analysis for Avastin ® in ophthalmology

By Michels Stephan   Kurz-Levin Malaika   Schmitz Christian  

International Journal of Pharmaceutical and Healthcare Marketing, Vol. 3, Iss. 1, 2009-04 ,pp. : 59-73

Emerald Group Publishing Ltd

Access to resources Recommend Favorite

Safety evaluation of laninamivir octanoate hydrate through analysis of adverse events reported during early post-marketing phase vigilance

By Nakano Takashi  

Scandinavian Journal of Infectious Diseases, Vol. 45, Iss. 6, 2013-06 ,pp. : 469-477

Informa Healthcare

Access to resources Recommend Favorite

Off-Label Use of Drugs and Adverse Drug Reactions in Pediatric Units: A Prospective, Multicenter Study

By  

Current Drug Safety, Vol. 13, Iss. 3, 2018-11 ,pp. : 200-207

Bentham Science Publishers

Access to resources Recommend Favorite

Liver injury with novel oral anticoagulants: assessing post‐marketing reports in the US Food and Drug Administration adverse event reporting system

By  

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 80, Iss. 2, 2015-08 ,pp. : 285-293

John Wiley & Sons Inc

Access to resources Recommend Favorite